Drug makers may now have to provide safety warnings not just for their own products but also for those of companies piggybacking on their success. A California appellate court stunned drug makers Friday, in what the court called a case of first impression, by ruling that name-brand drug makers can be held liable for harm caused by competing companies' generic versions. Product liability lawyer Mark Herrmann said the 1st District broke from several other states to reach its conclusion.
Name-Brand Drug Makers Ruled Liable for Injuries From Other Manufacturers' Generics
November 10, 2008